SCHEMBL22418878

SCHEMBL22418878

O=C(O)N(c1ccccc1)c1ccc2[nH]ccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 9/20 0.50
SLC6A4 P31645 9/20 0.50
SLC6A3 Q01959 8/20 0.50
CTNNB1 P35222 1/20 0.49
WNT3A P56704 1/20 0.49
NPC1 O15118 2/20 0.48
MAPT P10636 1/20 0.48
RAB9A P51151 1/20 0.48
NPSR1 Q6W5P4 2/20 0.43
USP2 O75604 1/20 0.43
GAA P10253 1/20 0.43
ALOX15 P16050 1/20 0.43
RAD51 Q06609 1/20 0.43
GLI1 P08151 1/20 0.42
GLI2 P10070 1/20 0.42
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
PTGS2 P35354 1/20 0.40
ENPP2 Q13822 1/20 0.40
GLO1 Q04760 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6166853 0.88 SLC6A2 (0.48) SLC6A2SLC6A4SLC6A3CTNNB1WNT3A
SCHEMBL4463432 0.88 KDM4E (0.50) SLC6A2SLC6A4SLC6A3MAPTNPSR1
SCHEMBL27654632 0.81 NPC1 (0.49) SLC6A2SLC6A4SLC6A3CTNNB1WNT3A
SCHEMBL3632143 0.80 USP2 (0.48) SLC6A2SLC6A4SLC6A3CTNNB1WNT3A
SCHEMBL4362240 0.78 SLC6A2 (0.55) SLC6A2SLC6A4SLC6A3CTNNB1WNT3A
SCHEMBL9717426 0.78 SLC6A2 (0.46) SLC6A2SLC6A4SLC6A3CTNNB1WNT3A
SCHEMBL28166707 0.78 SLC6A2 (0.46) SLC6A2SLC6A4SLC6A3CTNNB1WNT3A
SCHEMBL28131512 0.75 MAOA (0.49) SLC6A2SLC6A4SLC6A3CTNNB1WNT3A
SCHEMBL15253052 0.74 MAOA (0.51) SLC6A2SLC6A4SLC6A3CTNNB1WNT3A
SCHEMBL8531102 0.74 NPC1 (0.43) SLC6A2SLC6A4SLC6A3CTNNB1WNT3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020184670-A1 METHOD FOR INTRODUCING DEUTERATED LOWER ALKYL INTO AMINE MOIETY OF COMPOUND CONTAINING SECONDARY AMINE 大塚製薬株式会社 2020-09-17 WO disclosed
CN-1921846-A Combinatorial therapy with an acetylcholinesterase inhibitor and (3AR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate AXONYX INC (US) 2007-02-28 CN disclosed